COX-2 as a potential biomarker and therapeutic target in melanoma. [electronic resource]
Producer: 20210910Description: 20-31 p. digitalISSN:- 2095-3941
- Animals
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Biomarkers, Tumor -- analysis
- Celecoxib -- pharmacology
- Clinical Trials as Topic
- Cyclooxygenase 2 -- analysis
- Cyclooxygenase 2 Inhibitors -- pharmacology
- Disease Models, Animal
- Disease Progression
- Humans
- Melanoma -- drug therapy
- Molecular Targeted Therapy -- methods
- Prognosis
- Progression-Free Survival
- Signal Transduction -- drug effects
- Skin -- immunology
- Skin Neoplasms -- drug therapy
- Tumor Escape -- drug effects
- Tumor Microenvironment -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.